Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Mesdopetam

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    IRLAB Reports Progress Ahead of Mesdopetam Phase III Program
    IRLAB Reports Progress Ahead of Mesdopetam Phase III Program

    29 Oct 2024

    // ACCESSWIRE

    https://www.accesswire.com/936480/irlab-reports-continued-progress-ahead-of-the-mesdopetam-phase-iii-program

    ACCESSWIRE
    29 Oct 2024
    Share Share
    IRLAB Receives End-of-Ph 2 Meeting Confirming Alignment with the FDA
    IRLAB Receives End-of-Ph 2 Meeting Confirming Alignment with the FDA

    22 Mar 2024

    // ACCESSWIRE

    https://www.accesswire.com/845836/irlab-receives-minutes-from-end-of-phase-2-meeting-confirming-alignment-with-the-fda-on-the-phase-iii-program-for-mesdopetam

    ACCESSWIRE
    22 Mar 2024
    Share Share
    IRLAB Provides Update on Mesdopetam's Phase IIb Study Data
    IRLAB Provides Update on Mesdopetam's Phase IIb Study Data

    21 Aug 2023

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=775597&lang=en

    ACCESSWIRE
    21 Aug 2023
    Share Share
    IRLAB reports LPLV Achieved in Phase IIb Clinical Study of Mesdopetam
    IRLAB reports LPLV Achieved in Phase IIb Clinical Study of Mesdopetam

    14 Dec 2022

    // ACCESSWIRE

    https://www.accesswire.com/731758/IRLAB-reports-Last-Patient-Last-Visit-LPLV-Achieved-in-Phase-IIb-Clinical-Study-of-Mesdopetam-in-PD-LIDs-with-Top-Line-Results-Anticipated-Mid-January-2023

    ACCESSWIRE
    14 Dec 2022
    Share Share
    IRLAB Completes Recruitment in Phase IIb Study of Mesdopetam (IRL790)
    IRLAB Completes Recruitment in Phase IIb Study of Mesdopetam (IRL790)

    12 Sep 2022

    // ACCESSWIRE

    https://www.accesswire.com/715500/IRLAB-Completes-Recruitment-in-Phase-IIb-Study-of-Mesdopetam-IRL790-in-Patients-with-Parkinsons-Levodopa-Induced-Dyskinesias

    ACCESSWIRE
    12 Sep 2022
    Share Share
    IRLAB's partner Ipsen Initiates Clinical Studies in Line with Mesdopetam's DevP
    IRLAB's partner Ipsen Initiates Clinical Studies in Line with Mesdopetam's DevP

    05 Sep 2022

    // ACCESSWIRE

    https://www.accesswire.com/714741/IRLABs-partner-Ipsen-Initiates-Clinical-Studies-in-Line-with-Mesdopetams-Development-Plan

    ACCESSWIRE
    05 Sep 2022
    Share Share